PERJETA
Concentrate for solution for infusion, 420mg
RxActive license
Active substance (INN)
pertuzumab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength420mg
PackagingUkupno 1 bočica staklena sa 14ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FD02)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateJune 28, 2024
Source: CInMED register